Search Results - "Goldberg, B. B"

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC by Grant, Michael J., Herbst, Roy S., Goldberg, Sarah B.

“…The treatment landscape of driver-negative non-small-cell lung cancer (NSCLC) is rapidly evolving. Immune-checkpoint inhibitors, specifically those targeting…”
Get full text

Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients by Kragstrup, Tue W, Singh, Helene Søgaard, Grundberg, Ida, Nielsen, Ane Langkilde-Lauesen, Rivellese, Felice, Mehta, Arnav, Goldberg, Marcia B, Filbin, Michael R, Qvist, Per, Bibby, Bo Martin

“…Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin converting enzyme 2 (ACE2) enabling entrance of the virus into cells and…”
Get full text

Psychiatric symptoms, risk, and protective factors among university students in quarantine during the COVID-19 pandemic in China by Sun, Shufang, Goldberg, Simon B, Lin, Danhua, Qiao, Shan, Operario, Don

“…The COVID-19 pandemic has made unprecedented impact on the psychological health of university students, a population vulnerable to distress and mental health…”
Get full text

A Comprehensive Update on the Chylomicronemia Syndrome by Goldberg, Ronald B, Chait, Alan

“…The chylomicronemia syndrome is characterized by severe hypertriglyceridemia and fasting chylomicronemia and predisposes affected individuals to acute…”
Get full text

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study by Antonia, Scott, Prof, Goldberg, Sarah B, MD, Balmanoukian, Ani, MD, Chaft, Jamie E, MD, Sanborn, Rachel E, MD, Gupta, Ashok, MD, Narwal, Rajesh, PhD, Steele, Keith, PhD, Gu, Yu, PhD, Karakunnel, Joyson J, MD, Rizvi, Naiyer A, Prof

“…Summary Background PD-L1 and CTLA-4 immune checkpoints inhibit antitumour T-cell activity. Combination treatment with the anti-PD-L1 antibody durvalumab and…”
Get full text

Long tailed trions in monolayer MoS2: Temperature dependent asymmetry and resulting red-shift of trion photoluminescence spectra by Christopher, Jason W., Goldberg, Bennett B., Swan, Anna K.

“…Monolayer molybdenum disulfide (MoS 2 ) has emerged as a model system for studying many-body physics because the low dimensionality reduces screening leading…”
Get full text

High-Throughput Detection and Sizing of Individual Low-Index Nanoparticles and Viruses for Pathogen Identification by Daaboul, G. G, Yurt, A, Zhang, X, Hwang, G. M, Goldberg, B. B, Ünlü, M. S

“…Rapid, chip-scale, and cost-effective single particle detection of biological agents is of great importance to human health and national security. We report…”
Get full text

Direct binding of polymeric GBP1 to LPS disrupts bacterial cell envelope functions by Kutsch, Miriam, Sistemich, Linda, Lesser, Cammie F, Goldberg, Marcia B, Herrmann, Christian, Coers, Jörn

“…In the outer membrane of gram‐negative bacteria, O‐antigen segments of lipopolysaccharide (LPS) form a chemomechanical barrier, whereas lipid A moieties anchor…”
Get full text

The RhlR quorum-sensing receptor controls Pseudomonas aeruginosa pathogenesis and biofilm development independently of its canonical homoserine lactone autoinducer by Mukherjee, Sampriti, Moustafa, Dina, Smith, Chari D, Goldberg, Joanna B, Bassler, Bonnie L

“…Quorum sensing (QS) is a bacterial cell-to-cell communication process that relies on the production, release, and response to extracellular signaling molecules…”
Get full text

FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1 by Fashoyin‐Aje, Lola, Donoghue, Martha, Chen, Huanyu, He, Kun, Veeraraghavan, Janaki, Goldberg, Kirsten B, Keegan, Patricia, McKee, Amy E, Pazdur, Richard

“…On September 22, 2017, the U.S. Food and Drug Administration (FDA) granted accelerated approval for pembrolizumab (Keytruda, Merck & Co., Inc., Whitehouse…”
Get full text

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody by Maher, V Ellen, Fernandes, Laura L, Weinstock, Chana, Tang, Shenghui, Agarwal, Sundeep, Brave, Michael, Ning, Yang-Min, Singh, Harpreet, Suzman, Daniel, Xu, James, Goldberg, Kirsten B, Sridhara, Rajeshwari, Ibrahim, Amna, Theoret, Marc, Beaver, Julia A, Pazdur, Richard

“…To assess the relationship among tumor response rate, overall survival, and the development of related adverse events of special interest (AESIs) or related…”
Get full text

Transfer of CVD-Grown Monolayer Graphene onto Arbitrary Substrates by Suk, Ji Won, Kitt, Alexander, Magnuson, Carl W, Hao, Yufeng, Ahmed, Samir, An, Jinho, Swan, Anna K, Goldberg, Bennett B, Ruoff, Rodney S

“…Reproducible dry and wet transfer techniques were developed to improve the transfer of large-area monolayer graphene grown on copper foils by chemical vapor…”
Get full text

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer by Robichaux, Jacqulyne P., Elamin, Yasir Y., Tan, Zhi, Carter, Brett W., Zhang, Shuxing, Liu, Shengwu, Li, Shuai, Chen, Ting, Poteete, Alissa, Estrada-Bernal, Adriana, Le, Anh T., Truini, Anna, Nilsson, Monique B., Sun, Huiying, Roarty, Emily, Goldberg, Sarah B., Brahmer, Julie R., Altan, Mehmet, Lu, Charles, Papadimitrakopoulou, Vassiliki, Politi, Katerina, Doebele, Robert C., Wong, Kwok-Kin, Heymach, John V.

“…Although most activating mutations of epidermal growth factor receptor (EGFR)-mutant non–small cell lung cancers (NSCLCs) are sensitive to available EGFR…”
Get full text

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes by Goldberg, Ronald B, Stone, Neil J, Grundy, Scott M

“…The American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines recently published its 2018 recommendations on…”
Get full text

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study by Aroda, Vanita R, Edelstein, Sharon L, Goldberg, Ronald B, Knowler, William C, Marcovina, Santica M, Orchard, Trevor J, Bray, George A, Schade, David S, Temprosa, Marinella G, White, Neil H, Crandall, Jill P, the Diabetes Prevention Program Research Group

“…Context: Vitamin B12 deficiency may occur with metformin treatment, but few studies have assessed risk with long-term use. Objective: To assess the risk of B12…”
Get full text

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA by Goldberg, Sarah B, Narayan, Azeet, Kole, Adam J, Decker, Roy H, Teysir, Jimmitti, Carriero, Nicholas J, Lee, Angela, Nemati, Roxanne, Nath, Sameer K, Mane, Shrikant M, Deng, Yanhong, Sukumar, Nitin, Zelterman, Daniel, Boffa, Daniel J, Politi, Katerina, Gettinger, Scott N, Wilson, Lynn D, Herbst, Roy S, Patel, Abhijit A

“…Decisions to continue or suspend therapy with immune checkpoint inhibitors are commonly guided by tumor dynamics seen on serial imaging. However, immunotherapy…”
Get full text

Does Practice Quality Mediate the Relationship Between Practice Time and Outcome in Mindfulness-Based Stress Reduction? by Goldberg, Simon B., Knoeppel, Cara, Davidson, Richard J., Flook, Lisa

“…Interventions based on mindfulness meditation are increasingly common and evidence exists supporting their use. However, questions remain regarding treatment…”
Get full text

Man's best friend(s): Effects of a brief befriending meditation on human-animal relations by Simonsson, Otto, Goldberg, Simon B, Osika, Walter

“…In two studies using samples representative of the US adult population with regard to age, sex and ethnicity, we investigated relationships between…”
Get full text

FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond by Pai‐Scherf, Lee, Blumenthal, Gideon M., Li, Hongshan, Subramaniam, Sriram, Mishra‐Kalyani, Pallavi S., He, Kun, Zhao, Hong, Yu, Jingyu, Paciga, Mark, Goldberg, Kirsten B., McKee, Amy E., Keegan, Patricia, Pazdur, Richard

“…On October 24, 2016, the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda; Merck & Co., Inc., https://www.merck.com) for treatment of…”
Get full text

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations by Odogwu, Lauretta, Mathieu, Luckson, Blumenthal, Gideon, Larkins, Erin, Goldberg, Kirsten B., Griffin, Norma, Bijwaard, Karen, Lee, Eunice Y., Philip, Reena, Jiang, Xiaoping, Rodriguez, Lisa, McKee, Amy E., Keegan, Patricia, Pazdur, Richard

“…On June 22, 2017, the Food and Drug Administration expanded indications for dabrafenib and trametinib to include treatment of patients with metastatic…”
Get full text